Homburger | View firm profile
On December 13, 2022, Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a global insulin delivery and diabetes technology company, announced that it has entered into a definitive agreement to acquire AMF Medical SA, the privately held Swiss developer of the Sigi™ Patch Pump, an insulin delivery solution.
The consideration includes a previous strategic investment of CHF 8.0 m, an upfront cash payment of CHF 62.4 m, and additional contingent earnout payments of up to CHF 129.6 m, in aggregate, payable upon the achievement of certain milestones. The transaction is subject to the satisfaction of customary closing conditions and is expected to close in January 2023.
Homburger, who also advised AMF Medical on its previous financing rounds, acts as transaction counsel to AMF Medical SA and its shareholders. The Homburger team comprises Andreas Müller, Margrit Marti and Léonard Aeschlimann Perales (all Corporate / M&A; Healthcare / Life Sciences), Luca Dal Molin and Joel Fink (both IP / IT; Healthcare / Life Sciences), Stefan Oesterhelt, Kevin Müller and Philippe Weber (all Tax), Richard Stäuber and Allegra Arnold (both Competition; Healthcare / Life Sciences), and Marc Bircher and Sebastian Wyler (both Employment and Executive Compensation).
Contact
Nanding Susso / Marketing / [email protected]
December 14, 2022